MedPath

12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress

Phase 3
Terminated
Conditions
Depression
Sexual Dysfunctions, Psychological
Interventions
Registration Number
NCT01040208
Lead Sponsor
Sprout Pharmaceuticals, Inc
Brief Summary

The current trial will explore the safety of flibanserin in combination with Selective Serotonin Reuptake Inhibitors or Norepinephrine Serotonin Reuptake Inhibitors in a representative population of women with depressive and possible concurrent anxiety symptomatology.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
111
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
flibanserin 100 mg qhsflibanserin 100 mg qhsPatient to receive 2 flibanserin tablets of 50 mg qhs
flibanserin 50 mg to 100 mg qhsflibanserin 50 mg to 100 mg qhsPatient to receive one tablet of flibanserin 50 mg and one tablet of flibanserin placebo qhs for 14 days then will receive 2 flibanserin tablets of 50 mg qhs
placebo 2 tablets qhsplacebo 2 tablets qhsPatient to receive 2 placebo tablets of 50 mg qhs
Primary Outcome Measures
NameTimeMethod
The Primary Safety Endpoint is the Occurrence of Adverse Events During the Treatment and Post Treatment Period.17 weeks
Secondary Outcome Measures
NameTimeMethod
The Occurrence of Mild Depressive Symptoms (i.e., a Total Score of '7' to '11', Inclusive) That Have Remitted (i.e., a Total Score of '6' or Less) on the 16 Item Quick Inventory of Depressive Symptoms - Self Report at Visit 6 (Week 12)12 weeks
The Occurrence of Mild Anxiety Symptoms (i.e., a Total Score of '8' to '16', Inclusive) That Have Remitted (i.e., a Total Score of '7' or Less) on the Beck Anxiety Inventory at Visit 6 (Week 12)12 weeks

Trial Locations

Locations (39)

Western Affiliated Research Institute

🇺🇸

Denver, Colorado, United States

Albuquerque Neuroscience

🇺🇸

Albuquerque, New Mexico, United States

Clinco

🇺🇸

Terre Haute, Indiana, United States

Future Search Trials

🇺🇸

Austin, Texas, United States

Alliance Research Group

🇺🇸

Richmond, Virginia, United States

Millennium Psychiatric Associates

🇺🇸

Creve Coeur, Missouri, United States

Bio Behavioral Health

🇺🇸

Toms River, New Jersey, United States

IPS Research Company

🇺🇸

Oklahoma City, Oklahoma, United States

Stedman Clinical Trials

🇺🇸

Tampa, Florida, United States

Schuster Medical Research

🇺🇸

Sherman Oaks, California, United States

Capstone Clinical Research

🇺🇸

Livertyville, Illinois, United States

ActivMed Practices and Research

🇺🇸

Haverhill, Massachusetts, United States

Medical and Behavioral Health Research

🇺🇸

New York, New York, United States

Bioscience Research

🇺🇸

Mount Kisco, New York, United States

Mary Ann Knesevich

🇺🇸

Irving, Texas, United States

Mood & Anxiety Research

🇺🇸

Fresno, California, United States

Gulf Coast Clinical Research

🇺🇸

Fort Myers, Florida, United States

Kolin Research Group

🇺🇸

Winter Park, Florida, United States

Comprehensive Neuroscience

🇺🇸

Atlanta, Georgia, United States

Psychiatric Medicine Associates

🇺🇸

Skokie, Illinois, United States

Sheppard Pratt Hospital

🇺🇸

Baltimore, Maryland, United States

Atlanta Institute of Medicine & Research

🇺🇸

Atlanta, Georgia, United States

CRI Worldwide

🇺🇸

Philadelphia, Pennsylvania, United States

San Antonio Psychiatric Research Center

🇺🇸

San Antonio, Texas, United States

Clinical Trials Technology

🇺🇸

Prairie Village, Kansas, United States

Clinical Innovations

🇺🇸

Riverside, California, United States

Synergy Clinical Research Center

🇺🇸

National City, California, United States

Diablo Clinical Research

🇺🇸

Walnut Creek, California, United States

Ali Kashfi

🇺🇸

Altamonte Springs, Florida, United States

Sarkis Clinical Trials

🇺🇸

Gainesville, Florida, United States

Chicago Research Center

🇺🇸

Chicago, Illinois, United States

Social Psychiatry Research Institute

🇺🇸

Brooklyn, New York, United States

Neurobehavioral Research

🇺🇸

Cedarhurst, New York, United States

MIdwest Clinical Research Center

🇺🇸

Dayton, Ohio, United States

Suburban Research Associates

🇺🇸

Media, Pennsylvania, United States

Clinical Trials of Texas

🇺🇸

San Antonio, Texas, United States

University of Cincinnati

🇺🇸

Cincinnati, Ohio, United States

Clinical Neuroscience Solutions

🇺🇸

Memphis, Tennessee, United States

Radiant Research

🇺🇸

Denver, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath